Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 925 of 1863 entries
View as:

Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00027729 Org: User:
Start: 06/30/01 End: 11/30/04 Due: 11/30/05

A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05886634 Org: User:
Start: 05/23/23 End: 05/23/27 Due: 05/23/28

Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03520504 Org: User:
Start: 04/26/18 End: 12/22/22 Due: 12/22/23

Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00423930 Org: User:
Start: 10/31/06 End: 07/31/16 Due: 07/31/17

Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06728579 Org: User:
Start: 12/06/24 End: 12/31/28 Due: 12/31/29

A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00706875 Org: User:
Start: 06/30/08 End: 04/30/18 Due: 04/30/19

A Model for Genetic Susceptibility: Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00591500 Org: User:
Start: 11/30/99 End: 07/31/25 Due: 07/31/26

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00940524 Org: User:
Start: 07/31/09 End: 04/30/14 Due: 04/30/15

Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244

Phase: N/A Priority: Normal
NCT ID: NCT00970359 Org: User:
Start: 09/30/09 End: 04/30/13 Due: 04/30/14

Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Phase: N/A Priority: Normal
NCT ID: NCT02684253 Org: User:
Start: 02/11/16 End: 01/22/21 Due: 01/22/22

Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01127373 Org: User:
Start: 05/11/10 End: 10/02/19 Due: 10/02/20

PS-341 in Treating Patients With Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00017329 Org: User:
Start: 04/30/01 End: - Due: -

TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00022347 Org: User:
Start: 05/31/01 End: 12/31/09 Due: 12/31/10

Cognitive Functioning and Quality of Life in CNS Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00581737 Org: User:
Start: 07/31/00 End: 08/31/09 Due: 08/31/10

A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05910294 Org: User:
Start: 06/01/23 End: 06/30/27 Due: 06/30/28

A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Phase: N/A Priority: Normal
NCT ID: NCT04920084 Org: User:
Start: 06/03/21 End: 06/30/25 Due: 06/30/26

Acupuncture for the Treatment of Chronic Lymphedema

Phase: N/A Priority: Normal
NCT ID: NCT01003951 Org: User:
Start: 10/31/09 End: 08/31/12 Due: 08/31/13

Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04329325 Org: User:
Start: 03/30/20 End: 03/31/26 Due: 03/31/27

Chemotherapy, Radiation Therapy, Immunotherapy, and Bone Marrow Transplantation in Treating Patients With Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00002634 Org: User:
Start: 02/28/95 End: 09/30/04 Due: 09/30/05

External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas

Phase: N/A Priority: Normal
NCT ID: NCT01012609 Org: User:
Start: 10/30/09 End: 01/15/18 Due: 01/15/19

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00055705 Org: User:
Start: 01/31/03 End: - Due: -

Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02023333 Org: User:
Start: 12/31/13 End: 12/31/25 Due: 12/31/26

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT01383759 Org: User:
Start: 06/24/11 End: 04/30/19 Due: 04/30/20

Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00776867 Org: User:
Start: 10/31/08 End: 07/31/17 Due: 07/31/18

Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04458532 Org: User:
Start: 10/08/20 End: 03/31/27 Due: 03/31/28